{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T05:17:33Z","timestamp":1787807853655,"version":"build-2784847793"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jconrel.2026.115135","type":"journal-article","created":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T14:18:26Z","timestamp":1782656306000},"page":"115135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A COX-2 PROTAC Nanodrug for osteoarthritis therapy via enhancing cartilage repair and reprogramming macrophage polarization"],"prefix":"10.1016","volume":"397","author":[{"given":"Chong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linsen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianjie","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchuang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengqi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.115135_bb0005","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0140-6736(14)60802-3","article-title":"Osteoarthritis","volume":"386","author":"Glyn-Jones","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2026.115135_bb0010","first-page":"504","article-title":"Osteoarthritis: cartilage matrix stiffness regulates chondrocyte metabolism and OA pathogenesis","volume":"11","author":"Onuora","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jconrel.2026.115135_bb0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41572-025-00594-6","article-title":"Osteoarthritis","volume":"11","author":"Tang","year":"2025","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jconrel.2026.115135_bb0020","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017","volume":"392","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2026.115135_bb0025","article-title":"Temporal trends in the disease burden of osteoarthritis from 1990 to 2019, and projections until 2030","volume":"18","author":"Chen","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2026.115135_bb0030","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/j.semarthrit.2015.11.007","article-title":"Efficacy and safety of topical NSAIDs in the management of osteoarthritis: evidence from real-life setting trials and surveys","volume":"45","author":"Rannou","year":"2016","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jconrel.2026.115135_bb0035","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41584-020-0447-8","article-title":"Core and adjunctive interventions for osteoarthritis: efficacy and models for implementation","volume":"16","author":"Bowden","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jconrel.2026.115135_bb0040","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1038\/s12276-021-00710-y","article-title":"Disease-modifying therapeutic strategies in osteoarthritis: current status and future directions","volume":"53","author":"Cho","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jconrel.2026.115135_bb0045","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.2174\/0929867325666180514112124","article-title":"Cyclooxygenase-2 inhibitors as a therapeutic target in inflammatory diseases","volume":"26","author":"Ferrer","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jconrel.2026.115135_bb0050","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2022.37.e148","article-title":"COX-2 inhibitor use as an early treatment option for knee osteoarthritis patients in Korea: a population-based cross-sectional study","volume":"37","author":"Cho","year":"2022","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.jconrel.2026.115135_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21186962","article-title":"Chondroprotective actions of selective COX-2 inhibitors in vivo: a systematic review","volume":"21","author":"Timur","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115135_bb0060","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.joca.2018.05.021","article-title":"Disease-modifying effects of COX-2 selective inhibitors and non-selective NSAIDs in osteoarthritis: a systematic review","volume":"26","author":"Nakata","year":"2018","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.jconrel.2026.115135_bb0065","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1126\/science.1224398","article-title":"Physiology. COX-2 inhibitors and cardiovascular risk","volume":"336","author":"Cannon","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.115135_bb0070","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/joim.13505","article-title":"Lessons from 20 years with COX-2 inhibitors: importance of dose-response considerations and fair play in comparative trials","volume":"292","author":"Stiller","year":"2022","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.jconrel.2026.115135_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107624","article-title":"Cyclooxygenases and the cardiovascular system","volume":"217","author":"Mitchell","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2026.115135_bb0080","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC targeted protein degraders: the past is prologue","volume":"21","author":"B\u00e9k\u00e9s","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.115135_bb0085","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.tips.2020.04.005","article-title":"Emerging new concepts of degrader technologies","volume":"41","author":"Ding","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jconrel.2026.115135_bb0090","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.chembiol.2020.07.020","article-title":"PROTACs: an emerging therapeutic modality in precision medicine","volume":"27","author":"Nalawansha","year":"2020","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.jconrel.2026.115135_bb0095","doi-asserted-by":"crossref","first-page":"28502","DOI":"10.1021\/acsnano.4c09800","article-title":"Advancing proteolysis targeting chimera (PROTAC) nanotechnology in protein homeostasis reprograming for disease treatment","volume":"18","author":"Wu","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115135_bb0100","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1039\/D1CS00762A","article-title":"Proteolysis-targeting chimera (PROTAC) delivery system: advancing protein degraders towards clinical translation","volume":"51","author":"Chen","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2026.115135_bb0105","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/d41573-021-00052-4","article-title":"Targeted protein degraders crowd into the clinic","volume":"20","author":"Mullard","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.115135_bb0110","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41392-022-00966-4","article-title":"Targeted protein degradation: mechanisms, strategies and application","volume":"7","author":"Zhao","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.115135_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1844","article-title":"New insights in osteoarthritis diagnosis and treatment: nano-strategies for an improved disease management. Wiley interdisciplinary reviews","volume":"15","author":"Paesa","year":"2023","journal-title":"Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.115135_bb0120","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.115135_bb0125","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.addr.2020.07.010","article-title":"Advanced nanomedicines for the treatment of inflammatory diseases","volume":"157","author":"Brusini","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115135_bb0130","doi-asserted-by":"crossref","first-page":"8461","DOI":"10.1021\/ac301678z","article-title":"A procedure for alcian blue staining of mucins on polyvinylidene difluoride membranes","volume":"84","author":"Dong","year":"2012","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jconrel.2026.115135_bb0135","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.joca.2007.03.006","article-title":"The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129\/SvEv mouse","volume":"15","author":"Glasson","year":"2007","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.jconrel.2026.115135_bb0140","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.joca.2019.06.011","article-title":"OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis","volume":"27","author":"Bannuru","year":"2019","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.jconrel.2026.115135_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2020.102213","article-title":"Double hydrophilic block copolymers self-assemblies in biomedical applications","volume":"283","author":"El Jundi","year":"2020","journal-title":"Adv. Colloid Interf. Sci."},{"key":"10.1016\/j.jconrel.2026.115135_bb0150","doi-asserted-by":"crossref","first-page":"6681","DOI":"10.1021\/acs.biomac.4c00885","article-title":"Biocompatible glycopolymer-PLA amphiphilic hybrid block copolymers with unique self-assembly, uptake, and degradation properties","volume":"25","author":"Green","year":"2024","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2026.115135_bb0155","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jconrel.2003.12.021","article-title":"Self-porating polymersomes of PEG-PLA and PEG-PCL: hydrolysis-triggered controlled release vesicles","volume":"96","author":"Ahmed","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115135_bb0160","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.colsurfb.2018.02.037","article-title":"Polyelectrolyte complex nanoparticles based on chitosan and methoxy poly(ethylene glycol) methacrylate-co-poly(methylacrylic acid) for oral delivery of ibuprofen","volume":"165","author":"Shi","year":"2018","journal-title":"Colloid Surf. B-Biointerfaces"},{"key":"10.1016\/j.jconrel.2026.115135_bb0165","doi-asserted-by":"crossref","first-page":"7972","DOI":"10.1021\/acsami.6b16413","article-title":"Encapsulating therapeutic proteins with polyzwitterions for lower macrophage nonspecific uptake and longer circulation time","volume":"9","author":"Zhang","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2026.115135_bb0170","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.joca.2023.12.005","article-title":"Inflammation in osteoarthritis: our view on its presence and involvement in disease development over the years","volume":"32","author":"van den Bosch","year":"2024","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.jconrel.2026.115135_bb0175","doi-asserted-by":"crossref","first-page":"5944","DOI":"10.1002\/anie.200501428","article-title":"Intracellular protein degradation: from a vague idea, through the lysosome and the ubiquitin-proteasome system, and onto human diseases and drug targeting (nobel lecture)","volume":"44","author":"Ciechanover","year":"2005","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2026.115135_bb0180","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.joca.2020.01.007","article-title":"Macrophages regulate the progression of osteoarthritis","volume":"28","author":"Zhang","year":"2020","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.jconrel.2026.115135_bb0185","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.immuni.2016.02.015","article-title":"Macrophages in tissue repair, regeneration, and fibrosis","volume":"44","author":"Wynn","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2026.115135_bb0190","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: nomenclature and experimental guidelines","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2026.115135_bb0195","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nri2448","article-title":"Exploring the full spectrum of macrophage activation","volume":"8","author":"Mosser","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.115135_bb0200","doi-asserted-by":"crossref","first-page":"5589","DOI":"10.7150\/thno.124748","article-title":"Macrophage membrane-biomimetic cinnamaldehyde nanomedicine ameliorates inflammatory bowel disease by suppressing macrophage m1 polarization","volume":"16","author":"Huang","year":"2026","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.115135_bb0205","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.actbio.2025.11.041","article-title":"Oxygen-self-supplying biomimetic nanozymes synergize with methotrexate to reprogram macrophage polarization for rheumatoid arthritis therapy","volume":"209","author":"Lv","year":"2026","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2026.115135_bb0210","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3389\/fbioe.2018.00099","article-title":"Blood-contacting biomaterials: in vitro evaluation of the hemocompatibility","volume":"6","author":"Weber","year":"2018","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115135_bb0215","article-title":"Prodrug-loaded micelles targeting articular cavity reactive oxygen species for rheumatoid arthritis treatment","volume":"35","author":"Meng","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.jconrel.2026.115135_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13122886","article-title":"A review of rodent behavior, mobility, and pain modifications in response to destabilization of the medial meniscus injury","volume":"13","author":"Kloser","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.jconrel.2026.115135_bb0225","doi-asserted-by":"crossref","first-page":"17932","DOI":"10.1021\/acsami.4c19160","article-title":"Reprogramming macrophage phenotype using a reactive oxygen species-responsive liposome delivery system for inflammation microenvironment remodeling and osteoarthritis treatment","volume":"17","author":"Lai","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2026.115135_bb0230","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1744-8069-10-36","article-title":"Peripheral administration of morphine attenuates postincisional pain by regulating macrophage polarization through COX-2-dependent pathway","volume":"10","author":"Godai","year":"2014","journal-title":"Mol. Pain"},{"key":"10.1016\/j.jconrel.2026.115135_bb0235","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/215283","article-title":"PPAR activation induces m1 macrophage polarization via cPLA\u2082-COX-2 inhibition, activating ROS production against leishmania mexicana","volume":"2013","author":"D\u00edaz-Gandarilla","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.jconrel.2026.115135_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2025.1526092","article-title":"Imrecoxib attenuates osteoarthritis by modulating synovial macrophage polarization through inactivating COX-2\/PGE2 signaling pathway","volume":"13","author":"Peng","year":"2025","journal-title":"Front. Bioeng. Biotechnol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926005389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926005389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:20:45Z","timestamp":1787804445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926005389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":48,"alternative-id":["S0168365926005389"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115135","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A COX-2 PROTAC Nanodrug for osteoarthritis therapy via enhancing cartilage repair and reprogramming macrophage polarization","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115135","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115135"}}